Algopix Logo
Low Inventory

LUCIRA® by Pfizer COVID-19 & Flu Home Test, Results in 30 Minutes, Emergency Use Authorized (EUA), First and Only At-Home Test for COVID-19 and Flu A/B

Best offer in the last 28 days!Golden Dollar
Marketplace
Price
Low Inventory

Product Information

  • PRODUCT SHELF LIFE MINIMUM: March 2024
  • FIRST 2-in-1 SINGLE-USE HOME TEST FOR COVID-19 AND FLU A/B: Brings the power of lab testing technology to your home
  • AT-HOME TESTING: Quickly test for COVID-19 and Flu A/B in the comfort of your home-and get results in 30 minutes
  • HSA/FSA ELIGIBLE: Test may be reimbursed, depending on coverage; contact your health insurance company to learn more
  • FOR AGES 2+: Shallow, anterior nasal swab collection for individuals 14 years or older if self-collected or individuals 2 years or older if collected by an adult
  • Emergency Use Authorization LUCIRA by Pfizer COVID-19 & Flu Home Test has not been FDA cleared or approved but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA). It has been authorized only for the detection and differentiation of nucleic acid from SARS-CoV-2, influenza A, and influenza B, not for any other viruses or pathogens. This authorization is for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and//or diagnosis of COVID-19 under Section 564(b)(1) of Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
  • Please see product guide and document section below for authorized labeling for the LUCIRA by Pfizer COVID-19 & Flu Home Test

Product Identifiers

AIDAlgopix unique identifier
AIDMBSHJI001
Copied!

Similar Items

As an affiliate partner with eBay, Amazon, and Walmart, we earn from qualifying purchases. This means that we may receive a commission when you purchase products through links on our site. This does not affect the price you pay and helps us continue to provide valuable content. We appreciate your support.